1643570-23-3

(R)-Elsubrutinib ((R)-ABBV-105) is a Btk inhibitor. (R)-Elsubrutinib can be used in studies of immune diseases (such as rheumatoid arthritis, psoriasis, ankylosing spondylitis, asthma, systemic lupus erythematosus) and cancer[1].

Store at -20°C

[1] Dominique Bonafoux, et al. Primary carboxamides as Btk inhibitors. Patent WO2014210255Al.